-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.42179.13% Upside
Cano Health, Inc. Frequently Asked Questions
-
What analysts cover Cano Health, Inc.?
Cano Health, Inc. has been rated by research analysts at UBS, Citigroup, Cowen & Co. in the past 90 days.